186 related articles for article (PubMed ID: 12359083)
1. Elongation in a beta-structure promotes amyloid-like fibril formation of human lysozyme.
Goda S; Takano K; Yamagata Y; Maki S; Namba K; Yutani K
J Biochem; 2002 Oct; 132(4):655-61. PubMed ID: 12359083
[TBL] [Abstract][Full Text] [Related]
2. The stability and folding process of amyloidogenic mutant human lysozymes.
Takano K; Funahashi J; Yutani K
Eur J Biochem; 2001 Jan; 268(1):155-9. PubMed ID: 11121116
[TBL] [Abstract][Full Text] [Related]
3. Formation of amyloid aggregates from human lysozyme and its disease-associated variants using hydrostatic pressure.
De Felice FG; Vieira MN; Meirelles MN; Morozova-Roche LA; Dobson CM; Ferreira ST
FASEB J; 2004 Jul; 18(10):1099-101. PubMed ID: 15155566
[TBL] [Abstract][Full Text] [Related]
4. Lysozyme amyloidogenesis is accelerated by specific nicking and fragmentation but decelerated by intact protein binding and conversion.
Mishra R; Sörgjerd K; Nyström S; Nordigården A; Yu YC; Hammarström P
J Mol Biol; 2007 Feb; 366(3):1029-44. PubMed ID: 17196616
[TBL] [Abstract][Full Text] [Related]
5. Amyloid fibril formation of hen lysozyme depends on the instability of the C-helix (88-99).
Harada A; Azakami H; Kato A
Biosci Biotechnol Biochem; 2008 Jun; 72(6):1523-30. PubMed ID: 18540107
[TBL] [Abstract][Full Text] [Related]
6. In silico prediction of novel residues involved in amyloid primary nucleation of human I56T and D67H lysozyme.
Griffin JWD; Bradshaw PC
BMC Struct Biol; 2018 Jul; 18(1):9. PubMed ID: 30029603
[TBL] [Abstract][Full Text] [Related]
7. Reduced global cooperativity is a common feature underlying the amyloidogenicity of pathogenic lysozyme mutations.
Dumoulin M; Canet D; Last AM; Pardon E; Archer DB; Muyldermans S; Wyns L; Matagne A; Robinson CV; Redfield C; Dobson CM
J Mol Biol; 2005 Feb; 346(3):773-88. PubMed ID: 15713462
[TBL] [Abstract][Full Text] [Related]
8. Amyloid fibril formation and seeding by wild-type human lysozyme and its disease-related mutational variants.
Morozova-Roche LA; Zurdo J; Spencer A; Noppe W; Receveur V; Archer DB; Joniau M; Dobson CM
J Struct Biol; 2000 Jun; 130(2-3):339-51. PubMed ID: 10940237
[TBL] [Abstract][Full Text] [Related]
9. Effect of extra N-terminal residues on the stability and folding of human lysozyme expressed in Pichia pastoris.
Goda S; Takano K; Yamagata Y; Katakura Y; Yutani K
Protein Eng; 2000 Apr; 13(4):299-307. PubMed ID: 10810162
[TBL] [Abstract][Full Text] [Related]
10. A nanobody binding to non-amyloidogenic regions of the protein human lysozyme enhances partial unfolding but inhibits amyloid fibril formation.
De Genst E; Chan PH; Pardon E; Hsu SD; Kumita JR; Christodoulou J; Menzer L; Chirgadze DY; Robinson CV; Muyldermans S; Matagne A; Wyns L; Dobson CM; Dumoulin M
J Phys Chem B; 2013 Oct; 117(42):13245-13258. PubMed ID: 23919586
[TBL] [Abstract][Full Text] [Related]
11. Amyloid protofilament formation of hen egg lysozyme in highly concentrated ethanol solution.
Goda S; Takano K; Yamagata Y; Nagata R; Akutsu H; Maki S; Namba K; Yutani K
Protein Sci; 2000 Feb; 9(2):369-75. PubMed ID: 10716189
[TBL] [Abstract][Full Text] [Related]
12. Characterization of the structure and dynamics of amyloidogenic variants of human lysozyme by NMR spectroscopy.
Chamberlain AK; Receveur V; Spencer A; Redfield C; Dobson CM
Protein Sci; 2001 Dec; 10(12):2525-30. PubMed ID: 11714920
[TBL] [Abstract][Full Text] [Related]
13. Characterisation of the structural, dynamic and aggregation properties of the W64R amyloidogenic variant of human lysozyme.
Vettore N; Moray J; Brans A; Herman R; Charlier P; Kumita JR; Kerff F; Dobson CM; Dumoulin M
Biophys Chem; 2021 Apr; 271():106563. PubMed ID: 33640796
[TBL] [Abstract][Full Text] [Related]
14. Instability, unfolding and aggregation of human lysozyme variants underlying amyloid fibrillogenesis.
Booth DR; Sunde M; Bellotti V; Robinson CV; Hutchinson WL; Fraser PE; Hawkins PN; Dobson CM; Radford SE; Blake CC; Pepys MB
Nature; 1997 Feb; 385(6619):787-93. PubMed ID: 9039909
[TBL] [Abstract][Full Text] [Related]
15. Formation and seeding of amyloid fibrils from wild-type hen lysozyme and a peptide fragment from the beta-domain.
Krebs MR; Wilkins DK; Chung EW; Pitkeathly MC; Chamberlain AK; Zurdo J; Robinson CV; Dobson CM
J Mol Biol; 2000 Jul; 300(3):541-9. PubMed ID: 10884350
[TBL] [Abstract][Full Text] [Related]
16. Identification of a novel human islet amyloid polypeptide beta-sheet domain and factors influencing fibrillogenesis.
Jaikaran ET; Higham CE; Serpell LC; Zurdo J; Gross M; Clark A; Fraser PE
J Mol Biol; 2001 May; 308(3):515-25. PubMed ID: 11327784
[TBL] [Abstract][Full Text] [Related]
17. Spatial extent of charge repulsion regulates assembly pathways for lysozyme amyloid fibrils.
Hill SE; Miti T; Richmond T; Muschol M
PLoS One; 2011 Apr; 6(4):e18171. PubMed ID: 21483680
[TBL] [Abstract][Full Text] [Related]
18. Identification of the core structure of lysozyme amyloid fibrils by proteolysis.
Frare E; Mossuto MF; Polverino de Laureto P; Dumoulin M; Dobson CM; Fontana A
J Mol Biol; 2006 Aug; 361(3):551-61. PubMed ID: 16859705
[TBL] [Abstract][Full Text] [Related]
19. A comparative study of fibrillation kinetics of two homologous proteins under identical solution condition.
Chaudhary AP; Vispute NH; Shukla VK; Ahmad B
Biochimie; 2017 Jan; 132():75-84. PubMed ID: 27825804
[TBL] [Abstract][Full Text] [Related]
20. A highly amyloidogenic region of hen lysozyme.
Frare E; Polverino De Laureto P; Zurdo J; Dobson CM; Fontana A
J Mol Biol; 2004 Jul; 340(5):1153-65. PubMed ID: 15236974
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
